Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126585841 | 12658584 | 1 | I | 20160412 | 0 | 20160816 | 20160816 | DIR | 68.00 | YR | M | N | 88.50000 | KG | 20160722 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126585841 | 12658584 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | D | N | 0 | 200 | MG | 1X | ||||||
| 126585841 | 12658584 | 2 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | D | N | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126585841 | 12658584 | 1 | Osteosarcoma |
| 126585841 | 12658584 | 2 | Osteosarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126585841 | 12658584 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126585841 | 12658584 | Dysphagia | |
| 126585841 | 12658584 | Mucosal inflammation | |
| 126585841 | 12658584 | Neutropenia | |
| 126585841 | 12658584 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126585841 | 12658584 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126585841 | 12658584 | 1 | 20160330 | 20160330 | 0 | |
| 126585841 | 12658584 | 2 | 20160330 | 20160404 | 0 |